Trade SPTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Seaport Therapeutics, Inc. (SPTX) is trading at US$16.68, up 3.73% today as of Oct 14, 16:00 EDT. The company has a market capitalisation of US$1.3B. Over the past 52 weeks, SPTX has traded between US$14.85 and US$28.38. On Syfe you can trade SPTX with $0 commission and add it to your watchlist.
| Previous close | US$16.08 |
|---|---|
| Market cap | US$1.3B |
| 52-week range | US$14.85 – US$28.38 |
| Volume | 208.62K |
| Exchange | US |
Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc. is a clinical-stage therapeutics company, which engages in the provision of inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company was founded on April 1, 2024 and is headquartered in Boston, MA.
Year: 2026
Sector Update: Healthcare Stocks Mixed Premarket Wednesday
Sep 9, 1:16 PM · MT Newswires
Seaport Therapeutics, Inc. (SPTX) stock is trading at US$16.68, +3.73% from the previous close of US$16.08.
The market cap for Seaport Therapeutics, Inc. (SPTX) stock is approximately US$1.3B.
The 52-week high for Seaport Therapeutics, Inc. (SPTX) stock is US$28.38.
The 52-week low for Seaport Therapeutics, Inc. (SPTX) stock is US$14.85.
Seaport Therapeutics, Inc. (SPTX) does not currently pay a dividend.
Stay on top of SPTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
